Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

351 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Novel FLT3 point mutation in acute myeloid leukaemia.
Piccaluga PP, Bianchini M, Martinelli G. Piccaluga PP, et al. Among authors: bianchini m. Lancet Oncol. 2003 Oct;4(10):604. doi: 10.1016/s1470-2045(03)01219-1. Lancet Oncol. 2003. PMID: 14554237 No abstract available.
Denaturing-HPLC-based assay for detection of ABL mutations in chronic myeloid leukemia patients resistant to Imatinib.
Soverini S, Martinelli G, Amabile M, Poerio A, Bianchini M, Rosti G, Pane F, Saglio G, Baccarani M; Italian Cooerative Study Group on Chronic Myeloid Leukemia; European LeukemiaNet-6th Framework Program of the European Community. Soverini S, et al. Among authors: bianchini m. Clin Chem. 2004 Jul;50(7):1205-13. doi: 10.1373/clinchem.2004.031112. Epub 2004 Apr 23. Clin Chem. 2004. PMID: 15107311
Identification of a novel t(1;9)(q11;q34) in acute myelocytic leukemia.
Piccaluga PP, Luatti S, Ascani S, Bianchini M, Malagola M, Rondoni M, Gaitani S, Testoni N, Pileri SA, Baccarani M, Martinelli G, Visani G. Piccaluga PP, et al. Among authors: bianchini m. Cancer Genet Cytogenet. 2004 May;151(1):85-6. doi: 10.1016/j.cancergencyto.2003.08.025. Cancer Genet Cytogenet. 2004. PMID: 15120916 No abstract available.
Clinical outcome of chronic myeloid leukemia imatinib-resistant patients: do BCR-ABL kinase domain mutations affect patient survival? First multicenter Argentinean study.
Bengió RM, Riva ME, Moiraghi B, Lanari E, Milone J, Ventriglia V, Bullorsky E, Tezanos Pinto Md, Murro H, Bianchini M, Larripa I. Bengió RM, et al. Among authors: bianchini m. Leuk Lymphoma. 2011 Sep;52(9):1720-6. doi: 10.3109/10428194.2011.578310. Epub 2011 Jun 12. Leuk Lymphoma. 2011. PMID: 21663510
351 results